. On 3 April 2017, the Annual General Meeting of the Company’s shareholders passed resolution approved a decrease in the Company’s registered capital from Baht 664,892,534 to Baht 474,917,334 by
administrative expenses to revenues stood at 16.2%. Finance Cost Finance Cost for the year of 2018 was 133.6 million, decrease from 2017 56.7 million Baht or 73.8% increase. Major of the Company’s liabilities in
13% to 13% and 20% yoy. It was driven by the outstanding profit for the Company and its subsidiary. In addition, the significant improvement of return on equity was from the decrease of shareholders
tax assets 0.42 0.20 0.22 106.14 Total non-current assets 358.23 375.01 (16.78) (4.48) Details 31 Dec 2017 31 Dec 2016 Increase (Decrease) Percentage Total assets 729.13 561.39 167.74 29.88 Current
improve power supply capacity and escalate power to grid. Revenue from sale of industrial equipment dropped by 20.40% due to decrease in demand on products. Other revenues comprise of revenue from revenue
. Revenue from sale of industrial equipment dropped by 20.40% due to decrease in demand on products. Other revenues comprise of revenue from revenue from sale of scrap and zinc, machinery rental, together
from 77.3 percent to 87.3 percent and Ms. Kanjana Pongpatanadecha’s shareholding proportion shall decrease from 18.7 percent to 8.7 percent. The Company is therefore obligated to comply with the
Owners of the parent 27.96 8.19% 41.21 34.30% (13.25) (32.15%) Jan – Mar 63 Jan – Mar 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดั
2021 As at 31 December 2020 Increase/ (Decrease) % Increase/ (Decrease) Total assets 653.74 183.22 470.52 256.81% Total Liabilities 104.43 92.66 11.77 12.70% Total Equity 549.32 90.56 458.75 506.58